Android Apple

Myriad and Ultima to study UG 100 sequencing platform for genomics clinical tests

By Yahoo! Finance   |   2 months ago
Myriad and Ultima to study UG 100 sequencing platform for genomics clinical tests

Myriad Genetics partners with Ultima Genomics to explore UG 100 sequencing platform for clinical tests in oncology and reproductive genomics. The collaboration aims to improve test performance and reduce costs, benefiting emerging products like the Precise MRD test.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.